News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
Publication
Dermatology Times
More
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
    • Biologic Treatments for Moderate to Severe Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
    • Emerging Therapies Plaque Psoriasis
    • Treatments for Plaque Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Skin Cancer (Nonmelanoma)
  • Vitiligo
  • Wound Care
Advertisement

Dermavant

Advertisement

Articles by Dermavant

Dermavant Moves One Step Closer to Potential New Treatment Option for Patients with Plaque Psoriasis

ByDermavant
August 30th 2021
Advertisement

Latest Updated Articles

  •  Dermavant Moves One Step Closer to Potential New Treatment Option for Patients with Plaque Psoriasis
    Dermavant Moves One Step Closer to Potential New Treatment Option for Patients with Plaque Psoriasis

    Published: August 30th 2021 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results

2

The Weekly Roundup: December 1-5

3

Nearly Half of Female Psoriasis Patients Report IPV, Study Finds

4

Experts See Promise in AI for Atopic Dermatitis Care

5

New Analysis Finds Radiofrequency Microneedling Superior for Rosacea Erythema and Patient Satisfaction

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us